Home » Resources » Funding Opportunities

Funding Opportunities

The following information is intended for potential and previous VECD Fellows to apply for further funding opportunities. This page will be updated as new opportunities and notices are available, however this list is not exhaustive by any means. Please refer to NIH’s Guide to Grants and Contracts for further searches.

Funding Opportunities

Ongoing

Gilead Sciences Research Scholars Program. *Note most application cycles for 2017 have closed, however few are still open until March.
CEPI Call for Proposals from late pre-clinical stage through to Phase II for MARS, Lassa, Nipah.
NHLBI Priorities for HIV Research and Funding. Notice number: NOT-HL-17-486. Released February 6, 2017; no application deadline announced.
Update on Clinical Trial Funding Opportunity Announcement Policy. To be effective January 2018, all grant applications with plans to conduct clinical trials must be submitted in response to an FOA which specifically states that clinical trials are allowed.
Fellowships through the American Society of Tropical Medicine & Hygiene. Various deadline dates throughout the beginning of the year for fellowships with a focus in Tropical Medicine.

 

March 15, 2017

Tennessee CFAR Developmental Core Awards. The Tennessee Center For AIDS Research (CFAR) is requesting applications for CFAR Developmental Core Awards. These awards are intended to support studies for short periods of time (~1 year) to develop preliminary data for highly competitive extramural research applications. Up to $50,000 in awards.
The highest priority of this program is to support new investigators who do not have existing independent (e.g., R01) HIV research funding from the NIH. Recipients of mentored training grants (e.g. K awards) are welcome to apply. For the NIH definition of New Investigator see http://grants.nih.gov/grants/new_investigators/#definition.
Letter of intent is due March 15, 2017. Application deadline is May 5, 2017.

March 24, 2017

Application deadline for Medicines for Malaria Venture. MMV seeks research proposals related to malaria eradication, novel compounds and screening.

April 7, 2017

Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34). This Funding Opportunity Announcement (FOA) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention or treatment.

Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R21) Applications appropriate for this FOA could include formative basic behavioral and social science to better understand a step in the care continuum and/or multiple steps in the HIV care continuum, and initial development and pilot tests of innovative approaches for intervention. Letter of intent due 30 days prior to application due date (earliest April 7, 2017).

Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R01) Applications appropriate for this FOA could include formative basic behavioral and social science to better understand a step in the care continuum and/or multiple steps in the HIV care continuum, initial development and pilot tests of innovative approaches for intervention, and intervention efficacy trials. Letter of intent due 30 days prior to application due date (earliest due April 7, 2017).

Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R01) This Funding Opportunity Announcement (FOA) encourages implementation research projects designed in partnership with global and domestic service providers, to target the particular needs in the selected community, to achieve the 90/90/90 HIV prevention and treatment targets identified by HIV/AIDS global leadership. The targets for HIV testing are that 90% of all persons living with HIV know their status, for treatment initiation that 90% of those diagnosed receive timely and effective antiretroviral treatment (ART), and for optimal treatment and preventive benefit that 90% of those on treatment achieve sustained viral suppression.

Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R21). Read the above description of the 90/90/90. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism.

Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34). This Funding Opportunity Announcement (FOA) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention or treatment.

April 9, 2017

Margaret E. Mahoney Summer Fellowships in Health Policy. Must be master-level students currently enrolled in medical, dental, public health, public policy or graduate nursing schools in the United States. Students will conduct summer research projects on some aspect of health care delivery transformation for vulnerable populations and/or childhood health and development, with an emphasis on policy implications. Fellows are also require to have the opportunity to meet local and national health policy leaders.

May 7, 2017

Innovations in Mechanisms and Interventions to Address Mental Health in HIV Prevention and Care Continuum
(R01) (PA-17-136) and (R21) (PA-17-137)
Application Receipt/Submission Date(s): Earliest Submission Date May 7, 2017, Standard Dates Apply

May 8, 2017

Wellcome Training Fellowships in Public Health and Tropical Medicine. This scheme offers research experience and training to early-stage researchers from low- and middle-income countries. The scheme aims to support research that will improve public health and tropical medicine at a local, national and global level.

May 22, 2017

Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21)
(PAR-17-150)
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
Application Receipt/Submission Date(s): May 22, 2017, April 4, 2018, April 4, 2019

Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01)
(PAR-17-151)
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
Application Receipt/Submission Date(s): May 22, 2017, April 4, 2018, April 4, 2019, by 5:00 PM local time of applicant organization.

May 25, 2017

NICHD Research Education Programs (R25) In conjunction with Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). This FOA will support creative educational activities with a primary focus on Courses for Skills Development, which are encouraged to include hands-on research experiences. This FOA encourages applications to develop and conduct short-term research education programs to improve the knowledge and research skills of biomedical and behavioral scientists conducting research in areas relevant to the mission of NICHD.

June 29, 2017

Interaction of HIV and Neurodevelopment of Children in Resource-Limited Settings: Improving Assessments (R01).

Interaction of HIV and Neurodevelopment of Children in Resource-Limited Settings: Improving Assessments (R21)

The purpose of this funding opportunity is to invite applications on research focused on the development and/or improvement of tools and/or materials for the neurodevelopmental assessment of cognitive functioning of children, and their implementation in resource-limited settings with high rates of HIV.

June 30, 2017

Organization for Women in Science for the Developing World. Postgraduate training for Women scientists from Sub-Saharan Africa and Science- and technology-lagging countries at Centres of Excellence in the South. Duration up to 3 years.

July 2017

TB Control Drone Project. Looking for an exceptional MD or PhD to take a leadership role in executing a drone based innovative TB control project in Madagascar https://www.youtube.com/watch?v=g-Z0x0ZekTQ .  This 1-2 year fellowship will be based at Stony Brook University and operated out of the Center ValBio in Ranomafana, Madagascar. The selected fellow will be the primary person responsible for translating this vision into reality including devising and executing protocols, building and managing a local team, engaging national and local partners and conveying results in written and oral format. In short, this is an ideal cap stone project as one transitions from being a trainee to an independent academic career. The ultimate direction of that career could be as focused as TB or a broad as health care systems in remote settings.
Qualifications: an MD or PhD with a background in implementation or clinical research
an understanding of TB care and control
excellent interpersonal, verbal, written communication skills and academic record
fluency in English (fluency in French or Malagasy is highly desirable)
Interested applicants should email a description of their research interest and a Curriculum Vitae to:
Peter Small, MD
Founding Director, Stony Brook University Global Health Institute
peter.small@stonybrook.edu

August 7, 2017

Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21). In conjunction with Eunice Kennedy Shriver National Institute of Child Health and Human Development. The purpose of this funding opportunity announcement (FOA) is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in women during pregnancy and lactation.

Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R03). The overall goals of the FOA are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations.

Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01).

October 18, 2017

NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01). This Funding Opportunity Announcement (FOA) is to provide an avenue for basic scientists, clinicians and clinical scientists to jointly initiate and conduct translational research projects which translate basic research findings into clinical tools for better human health.

November 24, 2017

HIV Pathogenesis and the Oral Microbiota (R01). This funding opportunity announcement (FOA) encourages hypothesis driven basic and translational sciences that will enhance our understanding of the role of microbiota in changing the immune response to HIV pathogenesis in the oral cavity.